The values of defibrillation testing at implantable cardioverter defibrillator implantation

'And then there were none'

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Purpose of Review: Since its advent, implantable cardioverter defibrillator (ICD) intra-operative defibrillation testing (DFT) has been a standard practice to confirm its optimal configuration. However, due to advances in device and lead technology, which now facilitate successful device implantation, and due to growing number of ICD primary prevention patients, the need for DFT has recently been questioned. The purpose of this review is to summarize the pro and contra DFT arguments, according to benefits, risk and clinical relevance, trying to identify the candidates for whom DFT is really indicated. Recent Findings: There is an ongoing debate on the need for DFT at ICD implant due to significant DFT-related complications; recently, many electrophysiologists have chosen not to perform DFT in many cases. Recent literature findings document large differences of practice between different centres and countries. In particular, there has been major debate and concern over performing DFT in patients with heart failure, indicated for CRT-D implants (cardiac resynchronization therapy with defibrillator). Summary: Due to the potential for serious complications during DFT and expanding primary prevention ICD candidates, we agree with the growing tendency not to routinely perform DFT at implant, as the risks may overweigh the benefits.

Original languageEnglish
Pages (from-to)8-12
Number of pages5
JournalCurrent Opinion in Cardiology
Volume27
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Implantable Defibrillators
Primary Prevention
Equipment and Supplies
Cardiac Resynchronization Therapy
Defibrillators
Heart Failure
Technology

Keywords

  • cardiac resynchronization therapy
  • defibrillation testing
  • implantable cardioverter defibrillator

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{5951f9b37d974a27992df7787a483bd5,
title = "The values of defibrillation testing at implantable cardioverter defibrillator implantation: 'And then there were none'",
abstract = "Purpose of Review: Since its advent, implantable cardioverter defibrillator (ICD) intra-operative defibrillation testing (DFT) has been a standard practice to confirm its optimal configuration. However, due to advances in device and lead technology, which now facilitate successful device implantation, and due to growing number of ICD primary prevention patients, the need for DFT has recently been questioned. The purpose of this review is to summarize the pro and contra DFT arguments, according to benefits, risk and clinical relevance, trying to identify the candidates for whom DFT is really indicated. Recent Findings: There is an ongoing debate on the need for DFT at ICD implant due to significant DFT-related complications; recently, many electrophysiologists have chosen not to perform DFT in many cases. Recent literature findings document large differences of practice between different centres and countries. In particular, there has been major debate and concern over performing DFT in patients with heart failure, indicated for CRT-D implants (cardiac resynchronization therapy with defibrillator). Summary: Due to the potential for serious complications during DFT and expanding primary prevention ICD candidates, we agree with the growing tendency not to routinely perform DFT at implant, as the risks may overweigh the benefits.",
keywords = "cardiac resynchronization therapy, defibrillation testing, implantable cardioverter defibrillator",
author = "Maurizio Gasparini and Paola Galimberti and Carlo Ceriotti",
year = "2012",
month = "1",
doi = "10.1097/HCO.0b013e32834dc366",
language = "English",
volume = "27",
pages = "8--12",
journal = "Current Opinion in Cardiology",
issn = "0268-4705",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The values of defibrillation testing at implantable cardioverter defibrillator implantation

T2 - 'And then there were none'

AU - Gasparini, Maurizio

AU - Galimberti, Paola

AU - Ceriotti, Carlo

PY - 2012/1

Y1 - 2012/1

N2 - Purpose of Review: Since its advent, implantable cardioverter defibrillator (ICD) intra-operative defibrillation testing (DFT) has been a standard practice to confirm its optimal configuration. However, due to advances in device and lead technology, which now facilitate successful device implantation, and due to growing number of ICD primary prevention patients, the need for DFT has recently been questioned. The purpose of this review is to summarize the pro and contra DFT arguments, according to benefits, risk and clinical relevance, trying to identify the candidates for whom DFT is really indicated. Recent Findings: There is an ongoing debate on the need for DFT at ICD implant due to significant DFT-related complications; recently, many electrophysiologists have chosen not to perform DFT in many cases. Recent literature findings document large differences of practice between different centres and countries. In particular, there has been major debate and concern over performing DFT in patients with heart failure, indicated for CRT-D implants (cardiac resynchronization therapy with defibrillator). Summary: Due to the potential for serious complications during DFT and expanding primary prevention ICD candidates, we agree with the growing tendency not to routinely perform DFT at implant, as the risks may overweigh the benefits.

AB - Purpose of Review: Since its advent, implantable cardioverter defibrillator (ICD) intra-operative defibrillation testing (DFT) has been a standard practice to confirm its optimal configuration. However, due to advances in device and lead technology, which now facilitate successful device implantation, and due to growing number of ICD primary prevention patients, the need for DFT has recently been questioned. The purpose of this review is to summarize the pro and contra DFT arguments, according to benefits, risk and clinical relevance, trying to identify the candidates for whom DFT is really indicated. Recent Findings: There is an ongoing debate on the need for DFT at ICD implant due to significant DFT-related complications; recently, many electrophysiologists have chosen not to perform DFT in many cases. Recent literature findings document large differences of practice between different centres and countries. In particular, there has been major debate and concern over performing DFT in patients with heart failure, indicated for CRT-D implants (cardiac resynchronization therapy with defibrillator). Summary: Due to the potential for serious complications during DFT and expanding primary prevention ICD candidates, we agree with the growing tendency not to routinely perform DFT at implant, as the risks may overweigh the benefits.

KW - cardiac resynchronization therapy

KW - defibrillation testing

KW - implantable cardioverter defibrillator

UR - http://www.scopus.com/inward/record.url?scp=83055178809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83055178809&partnerID=8YFLogxK

U2 - 10.1097/HCO.0b013e32834dc366

DO - 10.1097/HCO.0b013e32834dc366

M3 - Article

VL - 27

SP - 8

EP - 12

JO - Current Opinion in Cardiology

JF - Current Opinion in Cardiology

SN - 0268-4705

IS - 1

ER -